Global Pharmaceutical Sales Expected To Reach $880 billion in 2011
This article was originally published in The Pink Sheet Daily
IMS Health says the pharmaceutical industry will do better in 2011 than it is doing this year, but a full rebound is not on the horizon, as generics and payor restrictions continue to take a toll.
You may also be interested in...
Cost Of Drug Treatment In Medicare's Top Therapeutic Areas Dropping Quickly With Generics, IMS Data Show
IMS exec says average cost per day of drug treatment in top 10 Part D drug classes will drop to about 50¢ a day by 2014.
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.